Director Michael R. Jaff disclosed an insider purchase of HeartBeam, Inc. (NASDAQ: BEAT) common stock on April 16, 2026. According to the filing, Jaff acquired 31,250 shares at $0.80 per share, representing a total outlay of $25,000. At the time of reporting the stock was trading at $0.81, close to its 52-week low of $0.54, after a year-to-date decline of 66%.
The purchase was executed in connection with HeartBeam's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, served as the sole bookrunner for the deal, which was priced on April 14, 2026 and closed on April 16, 2026. The filing notes that the shares acquired by the reporting person are held indirectly through the entity Open Book Healthcare.
Separately, the company confirmed the closing of a $10 million public offering in which it sold 12.5 million shares at $0.80 per share. The offering list of participants included the company's first commercial customer, ClearCardio, as well as executive leadership and institutional investors. HeartBeam said the proceeds will be used to support the product rollout.
The company also granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares to cover any over-allotments. The disclosure indicated that the offering's completion was subject to customary closing conditions.
On the analyst front, B. Riley has initiated coverage of HeartBeam with a Buy rating and assigned a $4.00 price target, noting the company's FDA-cleared, cable-free ECG device. D. Boral Capital likewise began coverage with a Buy rating and a $5.00 price target. These coverage starts were highlighted alongside the financing activity in the company's disclosures.
InvestingPro analysis included with the filings states the stock appears undervalued at current levels, and notes that a Pro Research Report for HeartBeam is available on the platform. The filing and related disclosures provide a snapshot of insider activity, recent capital raising, and new analyst coverage, while also documenting the company's current trading range and the terms of the completed offering.
Contextual note: The details above are drawn from the company's insider filing and its offering disclosures. The statements regarding pricing, share counts, participants in the offering, and analyst initiations reflect the information presented in those documents.